MDPI and ACS Style
Voulgaridi, I.; Sarrou, S.; Dadouli, A.; Peristeri, A.-M.; Nasika, A.; Onoufriadis, I.; Kyritsi, M.A.; Anagnostopoulos, L.; Theodoridou, A.; Avakian, I.;
et al. Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines. Vaccines 2022, 10, 1268.
https://doi.org/10.3390/vaccines10081268
AMA Style
Voulgaridi I, Sarrou S, Dadouli A, Peristeri A-M, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I,
et al. Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines. Vaccines. 2022; 10(8):1268.
https://doi.org/10.3390/vaccines10081268
Chicago/Turabian Style
Voulgaridi, Ioanna, Styliani Sarrou, Aikaterini Dadouli, Athanasia-Marina Peristeri, Asimina Nasika, Ilias Onoufriadis, Maria A. Kyritsi, Lemonia Anagnostopoulos, Aikaterini Theodoridou, Ioanna Avakian,
and et al. 2022. "Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines" Vaccines 10, no. 8: 1268.
https://doi.org/10.3390/vaccines10081268